Standard BioTools (LAB) Reports Q2 Loss, Tops Revenue Estimates

Standard BioTools (LAB) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.08 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company that makes equipment to control fluids would post a loss of $0.04 per share when it actually produced a loss of $0.04, delivering no surprise.Over the last four quarters, the company has surpassed consensus EPS estimates just once.Standard ...